Stellar Biotherapeutics

Stellar Biotherapeutics is a biotechnology company focused on developing next-generation regenerative medicines using induced pluripotent stem cell (iPSC) technology. The company specializes in creating off-the-shelf cell therapies designed to treat chronic and degenerative conditions, with a primary focus on metabolic and organ-specific diseases such as chronic kidney disease and type 2 diabetes. By leveraging its proprietary differentiation protocols, Stellar Biotherapeutics aims to produce high-purity, functional cell types that can restore organ function and improve patient outcomes. The company's approach seeks to overcome the limitations of traditional organ transplantation and current standard-of-care treatments through scalable and standardized cellular products.